ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
ARLZ
Delisted
ARLZ was delisted on the 20th of August, 2018.
63 hedge funds and large institutions have $17.1M invested in Aralez Pharmaceuticals Inc. in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
64% less call options, than puts
Call options by funds: $63K | Put options by funds: $175K
Holders
63
Holding in Top 10
–
Calls
$63K
Puts
$175K
Top Buyers
| 1 | +$679K | |
| 2 | +$264K | |
| 3 | +$156K | |
| 4 |
D.E. Shaw & Co
New York
|
+$136K |
| 5 |
Millennium Management
New York
|
+$108K |
Top Sellers
| 1 | -$2.28M | |
| 2 | -$751K | |
| 3 | -$495K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$451K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$123K |